SequantrixTM is a spin-out of the Uniklinik RWTH Aachen, Germany and is based on decade-long research and clinical expertise of Prof. Rafael Kramann and Prof. Rebekka Schneider in the field of fibrosis.
The Uniklinik RWTH Aachen has supported the spin-out process through its technology transfer organisation RWTH Innovation GmbH by transferring assets and IP and continues to keep close ties through joint research projects.